Effects of an Exercise Intervention on Taxane-induced Peripheral Neuropathy in Breast Cancer Survivors
1 other identifier
interventional
88
0 countries
N/A
Brief Summary
The purpose of this study is to examine the effects of an exercise program on the management of TIPN in breast cancer survivors. This experimental study utilizes purposive sampling to recruit 88 adults, newly diagnosed with stage I\~III breast cancer women, who are expected to be treated with Taxane chemotherapy in a medical center located in central Taiwan. Participants will be randomly allocated to the experimental or observational group. The main outcomes are peripheral neuropathy and neuropathic pain. The 3\~6 months home-based extremity exercise program will be intervened between newly diagnosed with breast cancer to the completion of chemotherapy. Participants have to perform a total of 50 minutes of exercise including the Ten Skilled Hand exercise fourth a day, 5 minutes each time and Buerger Allen exercise twice a day, 15 minutes each time. This study expects that the extremity exercise program will be able to prevent and manage peripheral neuropathy and neuropathic pain via increasing blood circulation. Moreover, the exercise program may also improve functioning and QOL in breast cancer survivors receiving Taxane chemotherapy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Dec 2022
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 26, 2022
CompletedStudy Start
First participant enrolled
December 1, 2022
CompletedFirst Posted
Study publicly available on registry
December 7, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2023
CompletedDecember 7, 2022
November 1, 2022
1.1 years
October 26, 2022
November 30, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The incidence and severity of peripheral neuropathy
Total Neuropathy Score- clinical version, pain 0\~100 Visual Analogue Scale, Identification Pain Questionnaire
Change of peripheral neuropathy from baseline measure at 6 months
Secondary Outcomes (1)
The score change in quality of life
Change of quality of life from baseline measure at 6 months
Study Arms (2)
Exercise group
EXPERIMENTALThe 3\~6 months home-based extremity exercise program will be intervened between newly diagnosed with breast cancer to the completion of chemotherapy. Participants have to perform a total of 50 minutes of exercise including the Ten Skilled Hand exercise fourth a day, 5 minutes each time and Buerger Allen exercise twice a day, 15 minutes each time.
Observational group
NO INTERVENTIONThe observational group will need to record the extra exercise performed and the exercise prescription will be distributed after the study.
Interventions
Participants have to perform a total of 50 minutes of exercise including the Ten Skilled Hand exercise fourth a day, 5 minutes each time and Buerger Allen exercise twice a day, 15 minutes each time before chemotherapy to the completion of chemotherapy.
Eligibility Criteria
You may qualify if:
- Participants will be randomly allocated to the experimental or observational group using the two strata: (1) adjuvant or neoadjuvant and (2) paclitaxel, docetaxel, or Taxane plus Platinum.
You may not qualify if:
- Participants who have peripheral neuropathy before chemotherapy or regular exercise are excluded.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (1)
Wang YJ, Hung MC, Wu CJ, Huang CC, Cao HW. Effects of an exercise program on chemotherapy-induced peripheral neuropathy in newly diagnosed breast cancer individuals receiving taxanes: a randomized controlled trial. Support Care Cancer. 2025 Nov 10;33(12):1036. doi: 10.1007/s00520-025-10121-8.
PMID: 41212417DERIVED
Study Officials
- PRINCIPAL INVESTIGATOR
Chih-Chiang Hung, Doctor
Taichung Veterans General Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 26, 2022
First Posted
December 7, 2022
Study Start
December 1, 2022
Primary Completion
December 31, 2023
Study Completion
December 31, 2023
Last Updated
December 7, 2022
Record last verified: 2022-11
Data Sharing
- IPD Sharing
- Will not share